Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% in a Year, but Here's What Really Matters for Investors

The CEO of Apogee Therapeutics sold 20,000 shares for approximately $1.50M on March 11, 2026. The disposition represented 1.71% of CEO Henderson's direct holdings per the Form 4; this appears to be a routine insider sale and is unlikely to have a material impact on the company's stock or broader market.

Analysis

The CEO of Apogee Therapeutics sold 20,000 shares for approximately $1.50M on March 11, 2026. The disposition represented 1.71% of CEO Henderson's direct holdings per the Form 4; this appears to be a routine insider sale and is unlikely to have a material impact on the company's stock or broader market.